Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$276M |
| 2 |
IBM
IBM
|
+$272M |
| 3 |
Procter & Gamble
PG
|
+$161M |
| 4 |
Colgate-Palmolive
CL
|
+$151M |
| 5 |
BBBY
Bed Bath & Beyond Inc
BBBY
|
+$146M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Verizon
VZ
|
+$405M |
| 2 |
CELG
Celgene Corp
CELG
|
+$207M |
| 3 |
Booking.com
BKNG
|
+$123M |
| 4 |
Eli Lilly
LLY
|
+$114M |
| 5 |
BEAM
BEAM INC COM STK (DE)
BEAM
|
+$109M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.92% |
| 2 | Healthcare | 13.46% |
| 3 | Consumer Discretionary | 11.99% |
| 4 | Industrials | 10.52% |
| 5 | Consumer Staples | 9.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LL
826
DELISTED
LL Flooring Holdings, Inc.
LL
| $10.3M | 0.02% |
+135,000
| New | +$11.2M |
|
827
Hilltop Holdings
HTH
$2.28B
| $10.2M | 0.02% |
482,037
-88,452
| -16% | -$1.94M |
|
|
CVSA
828
Covista Inc
CVSA
$4.49B
| $10.2M | 0.02% |
+240,600
| New | +$10.2M |
|
|
NTUS
829
DELISTED
Natus Medical Inc
NTUS
| $10.2M | 0.02% |
405,145
+237,200
| +141% | +$5.86M |
|
830
Dorman Products
DORM
$3.95B
| $10.2M | 0.02% |
206,400
+171,373
| +489% | +$9.35M |
|
831
Manulife Financial
MFC
$72.9B
| $10.2M | 0.02% |
512,178
+42,754
| +9% | +$808K |
|
832
Interactive Brokers
IBKR
$41.4B
| $10.2M | 0.02% |
1,743,600
-344,524
| -16% | -$1.98M |
|
|
DRII
833
DELISTED
DIAMOND RESORTS INTL, INC
DRII
| $10.1M | 0.02% |
436,100
+173,407
| +66% | +$3.4M |
|
|
PCL
834
DELISTED
PLUM CREEK TIMBER CO (REIT)
PCL
| $10.1M | 0.02% |
224,000
+179,173
| +400% | +$7.8M |
|
835
Dine Brands
DIN
$440M
| $10M | 0.02% |
126,200
+87,309
| +224% | +$6.89M |
|
|
SYT
836
DELISTED
Syngenta Ag
SYT
| $10M | 0.02% |
134,100
-120,200
| -47% | -$9.24M |
|
837
Choice Hotels
CHH
$4.71B
| $10M | 0.02% |
212,900
-14,500
| -6% | -$653K |
|
838
RTX Corp
RTX
$297B
| $10M | 0.02% |
137,925
-34,323
| -20% | -$2.53M |
|
|
HTWR
839
DELISTED
HEARTWARE INTERNATIONAL INC COM STK (DE)
HTWR
| $10M | 0.02% |
113,200
+86,073
| +317% | +$7.71M |
|
|
ACET
840
DELISTED
Aceto Corp
ACET
| $9.98M | 0.02% |
550,300
-107,100
| -16% | -$2.06M |
|
|
SGI
841
Somnigroup International
SGI
$14B
| $9.94M | 0.02% |
+666,000
| New | +$8.93M |
|
|
IRS
842
IRSA Inversiones y Representaciones
IRS
$1.25B
| $9.9M | 0.02% |
626,987
+29,797
| +5% | +$413K |
|
843
Genuine Parts
GPC
$18.7B
| $9.89M | 0.02% |
112,700
+88,900
| +374% | +$7.64M |
|
|
SCU
844
DELISTED
Sculptor Capital Management, Inc. Class A Common Stock
SCU
| $9.89M | 0.02% |
71,510
-94,580
| -57% | -$12.1M |
|
845
Wynn Resorts
WYNN
$10.5B
| $9.88M | 0.02% |
47,600
-209,000
| -81% | -$43.3M |
|
846
Watsco Inc
WSO
$12.9B
| $9.88M | 0.02% |
96,100
-128,164
| -57% | -$13M |
|
847
Culp Inc
CULP
$43.2M
| $9.86M | 0.02% |
566,396
+42,996
| +8% | +$785K |
|
|
BIRT
848
DELISTED
Actuate Corp
BIRT
| $9.86M | 0.02% |
2,066,296
+236,496
| +13% | +$1.15M |
|
|
GWR
849
DELISTED
Genesee & Wyoming Inc.
GWR
| $9.84M | 0.02% |
93,750
-187,900
| -67% | -$18.5M |
|
|
FRP
850
DELISTED
Fairpoint Communications, Inc.
FRP
| $9.82M | 0.02% |
702,800
-28,148
| -4% | -$394K |
|
Similar funds
Jim Simons's Q2 2014 Portfolio in Review
As of Q2 2014, Jim Simons held 3,246 positions worth $42.9B, up 2.9% from $41.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Jim Simons's Q2 2014 filing shows 450 new, 1,273 increased, 1,008 reduced and 492 closed positions. Its largest new stake was Procter & Gamble: 2,001,729 shares worth $157M. The largest sale was Verizon, an estimated $405M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q2 2014 buy was Procter & Gamble: 2,001,729 shares worth $157M.
- Jim Simons added most to Pfizer in Q2 2014, an estimated $276M increase.
- Jim Simons's biggest Q2 2014 reduction was Verizon, cutting an estimated $405M.
- Jim Simons fully exited Booking.com in Q2 2014, selling an estimated $123M.
- Jim Simons's ten largest holdings make up 14% of its $42.9B portfolio in Q2 2014.
- Jim Simons opened 450 new positions and closed 492 in Q2 2014.
- Jim Simons's portfolio value rose 2.9% quarter-over-quarter to $42.9B.
Based on Renaissance Technologies's 13F filing for Q2 2014, filed 13 Aug 2014.